Speaker Profile
M.D., Ph.D., CMO, Quell Tx
Biography
Luke Devey is a physician-scientist and biopharmaceutical executive whose career spans academic surgery, translational immunology, experimental medicine and senior leadership in global pharma, biotech and venture capital. His work has focuses on translating mechanistic insight into therapeutic development, from early target discovery and biomarker strategy through to early phase clinical studies. Luke served in roles of increasing responsibility at GSK and Celgene prior to leading Translational Sciences at Janssen Immunology, concurrent with a visiting Professorship in immunology at Oxford.
Luke serves currently as Chief Medical Officer at Quell Therapeutics, and Venture Partner at SV Health Investors. Quell is currently executing upon the CHILL Phase 1/2 study of autologous CD19 CAR-Treg therapy in refractory rheumatoid arthritis and systemic sclerosis, with clinical data anticipated in 2027.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
